📰 Session Display Date News
Session Display Date News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Session Display Date. Real-time updates on events, politics, business and more.
September 27, 2023
27.09.2023 - Spotlight on Novel, Targeted Technologies to Enhance Engraftment, Expansion and Persistence of AlloCAR T Cells Demonstration of Dagger Technology to Engineer CAR T cells to Selectively Eliminate CD70 Positive, Allo-Reactive Host Immune ... Seite 1
May 31, 2023
/PRNewswire/ -- Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the...
May 25, 2023
/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision...
May 16, 2023
/PRNewswire/ -- Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the...
May 11, 2023
Data Will Also Be Presented in a Poster Session at the American Society of Clinical Oncology Annual Meeting on June 3, 2023 SOUTH SAN FRANCISCO, Calif., May 11, 2023 -- Allogene Therapeutics,... | May 11, 2023
April 26, 2023
AGENUS INC. : News, information and stories for AGENUS INC. | Nasdaq: AGEN | Nasdaq
April 26, 2023
Registration-Directed RAMP-201 Trial Designed to Address High Unmet Need in Low-Grade Serous Ovarian Cancer, a Unique and Distinct Type of Ovarian Cancer with Limited Treatment Options ... | April 26, 2023
April 26, 2023
/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision...